Growth hormone therapy in elderly people: An age-delaying drug?

Fundamental and Clinical Pharmacology

Volumn 10, Issue 5, 1996, Pages 416-430

  Bouillanne, O ^a   Rainfray, M ^a   Tissandier, O ^a   Nasr, A ^a   Lahlou, A ^a   Cnockaert, X ^a   Piette, F ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

Aging; Body composition; Growth hormone; Insulin like growth factor 1; Metabolism

Indexed keywords

ANABOLIC AGENT; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; INSULIN; NEUROTRANSMITTER; PEPTIDE DERIVATIVE; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTHRALGIA; BODY COMPOSITION; CARPAL TUNNEL SYNDROME; CLINICAL TRIAL; EDEMA; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MYALGIA; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SURGERY;

EID: 0029738178     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00596.x     Document Type: Review

References (158)

1. Abribat T, Brazeau P, Davignon I, Garrel DR. Insulin-like growth factor-1 blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn. Clin Endocrinol 1993;39:583-9
2. Alba-Roth J, Muller OA, Schopohl J, Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 1988;67:1186-9
3. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH. Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 1985;34:124-9
4. Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995;172:896-900
5. Arvat E, Gianotti L, Grottoli S et al. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab 1994;79:1440-3
6. Baker PK, Conner SD, Doscher ME, Kraft LA, Ricks CA. Use of a synthetic growth hormone releasing hexapeptide to increase rate gain in rats. J Anim Sci 1984;59:220
7. Baumann G, Shaw MA. A second lower affinity growth hormone-binding protein in human plasma. J Clin Endocrinol Metab 1990;70:680-6
8. Baumann G, Shaw MA, Armburn K. Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism 1989;38:683-9
9. Baumann G, Stalor MW, Armburn K, Barsano CP, De Vries BC. A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 1986;62:134-41
10. Baxter RC, Cowell CT. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 1987;65: 432-40
11. Bellantoni MF, Harman SM, Cho D, Blackman MR. Effects of progestin-opposed transdermal estrogen administration on GH and IGF-1 in postmenopausal women of different ages. J Clin Endocrinol Metab 1991;72:172-8
12. Bengtsson BA. The consequences of growth hormone deficiency in adults. Acta Endocrinol 1993;128 (Suppl 2):2-5
13. Bengtsson BA, Eden S, Lönn L, Kvist et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-17
14. Bentham J, Rodriguez-Arnao J, Ross RJM. Acquired growth hormone resistance in patients with hypercatabolism. Horm Res 1993;40:87-91
15. Bercu BB, Diamond FB Jr. Growth hormone neurosecretory dysfunction. Clin Endocrinol Metab 1986;13:337-90
16. Berelowitz M, Szaho M, Frohmann LA. Somatomedin C mediates growth hormone negative feed-back by effects on both the hypothalamus and the pituitary. Science 1981; 212:1279-83
17. Binoux M, Hosenhlopp P. IGF and IGF-binding proteins. Comparison of human serum and lymph. J Clin Endocrinol Metab 1988;67:509-14
18. Black MM, Shuster S, Bottoms E. Skin collagen and thickness in acromegaly and hypopituitarism. Clin Endocrinol 1972;1:259-63
19. Blichert-Toft M. Stimulation of the release of corticotrophin and somatotrophin by metyrapone and arginine. Acta Endocrinol 1975;195 Suppl:65-85
20. Blum WF, Ranke MB. Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. Acta Pediatr Scand 1990;397 (Suppl):55-62
21. Boulware SD, TamborLane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-1 and insulin. Dose-response relationships in healthy young and middle-aged adults. Clin Invest 1994;93:1131-9
22. Bowers CY, Alster DK, Frentz JM. The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 1992;74:292-8
23. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537-45
24. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. Growth hormone (GH)-releasing peptide stimulates GH release in normal men, acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990;70:975-82
25. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991;128:2027-35
26. Brazeau P, Vale W, Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;178:77-9
27. Campagnoli C, Biglia N, Altare F et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serums levels. Gynecol Endocrinol 1993;7:251-8
28. Campbell GS, Christian LJ, Carter-Su C. Evidence for involvement of the growth hormone receptor-associated thyrosine kinase in actions of growth hormone. J Biol Chem 1993;268:7427-34
29. Catalioto RM, Ailhaud G, Negrel R. Diacylglycerol production induced by growth hormone in Ob 1771 preadipocytes arises from phosphatidylcholine breakdown. Biochem Biophys Res Commun 1990;173:840-68
30. Ceda GP, Denti L, Ceresini G et al. Androgens do not regulate the growth hormone response to GHRH in elderly men. Horm Metab Res 1989;21:695-6
31. Clemmons DR, Klibanski A, Underwood LE et al. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981;53:1247-50
32. Clemmons DR, Snyder KD, Williams R, Underwood L. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab 1987;64:878-83
33. Clemmons DR, Underwood LE, Dickerson RN et al. Use of plasma somatomedin C/insulin-like growth factor 1 measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr 1985;41:191-8
34. Codd KE, Shu AYL, Walker RF. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 1989;29: 1139-44
35. Cohn L, Feller AG, Rudman IW, Rudman D. Further observations on the effects of human growth hormone in elderly hyposomatomedinemic men. In: Bereu BB, Walker RF, eds. Growth Hormone II. Basic and Clinical Aspects. New York: Springer-Verlag, 1994;133-49
36. Cohn SH, Vaswani A, Zanzi I, Aloia MS, Roginski MZ, Ellis KJ. Changes in body composition with age measured by total-body neutron activation. Metabolism 1976; 25:85-95
37. Coiro V, Volpi R, Cavazzini U et al. Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline. J Gerontol 1991;46:155-8
38. Conway S, Richardson L, Speciale S. Interaction between norepinephrine and serotonin in the neuroendocrine control of GH release in the rat. Endocrinology 1990; 126:1022-30
39. Corpas R, Harman SM, Blackman MR. Human growth hormone and human aging. Endocrine Rev 1993a;14(1):20-39
40. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-1 levels in old men. J Clin Endocrinol Metab 1993b;76:134-8
41. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs) and the IGF-binding proteins. J Clin Endocrinol Metab 1992;75:762-7
42. Coward WA, Lunn PG. The biochemistry and physiology of kwashiorkor and marasmus. Br Med Bull 1981;37:19-24
43. Cuneo RC, Salomon F, Mc Gauley A, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992;37:387-97
44. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance. J Appl Physiol 1991a;70:695-700
45. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment in growth hormone deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 1991b:70:688-94
46. Cuneo RC, Salomon F, Wiles CM, Sönksen PH. Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 1990;33(Suppl 4):55-60
47. Cwyfan Hughes SC, Cotterill AM, Molloy AR et al. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J Endocrinol 1993;135:135-45
48. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor I production is inhibited in human sepsis. Arch Surg 1988; 123:1409-14
49. Dawson-Hugues B, Stern D, Goldman J. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement therapy. J Clin Endocrinol Metab 1986;63:424-32
50. Doglio A, Dani C, Grimaldi P, Ailhaud G. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. Proc Natl Acad Sci USA 1989;86:1148-52
51. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993;13: 296-301
52. Ezzat S, Melmed S. Are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991;72:245-9
53. Faria ACS, Beckenstein LW, Booth RA, Vaccaro VA, Asplin CM, Veldhuis JD. Pulsatile growth hormone in normal women during the menstrual cycle. Clin Endocrinol 1992;36:591-6
54. Felig P, Wahren J. Fuel homeostasis in exercise. N Engl J Med 1975;283:1078-84
55. Finkelstein JW, Roffwarg H, Boyar P. Age-related changes in the twenty-four hour spontaneous secretion of growth hormone in normal individuals. J Clin Endocrinol Metab 1972;35:665-70
56. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970;19: 653-63
57. Franchimont P, Urbain-Choffray D, Lambelin P. Effects of repetitive administration of growth hormone releasing hormone on growth hormone secretion, insulin-like growth factor I and bone metabolism in post-menopausal women. Acta Endocrinol 1989;120:121-8
58. Froesch ER, Hussain M. IGFs: function and clinical importance. (5) Therapeutic potential of rhIGF-I in diabetes and conditions of insulin resistance. J Intern Med 1993;234: 561-70
59. Ghigo E, Arvat E, Rizzi G et al. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging. Eur J Endocrinol 1994;131:499-503
60. Ghigo E, Goffi E, Nicolosi M et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990;71:1481-5
61. Ghigo E, Nicolosi M, Arvat E et al. Growth hormone secretion in Alzheimer's disease: studies with growth hormone-releasing hormone alone and combined with pyridostigmine or arginine. Dementia 1993;4:315-20
62. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994;220(2):19-24
63. Godowski PJ, Lenng DW, Meacham LR. Characterization of the human growth hormone receptor gene and the demonstration of a partial gene deletion in 2 patients with Laron type dwarfism. Proc Natl Acad Sci USA 1989;86:8083-8
64. Goodman HM. Separation of early and late responses of adipose tissue to growth hormone. Endocrinology 1981; 109:120-9
65. Goth MI, Lyons CE, Canny BY, Thorner MO. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992;139:939-44
66. Guistina A, Bussi AR, Jacobello C, Wehrenberg WB. Effects of recombinant human growth hormone (GH) on bone and intermediary Metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol 1995;80:122-9
67. Guistina A, Wehrenberg WB. Growth hormone neuroregulation in diabetes mellitus. Trends Endocrinol Metab 1994;5:73-8
68. Guler HP, Zapf J, Schimd CH, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol 1989;121:753-8
69. Haffner D, Schaefer F, Girard J, Ritz E, Mehis O. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 1994;93:1163-71
70. Hardouin S, Gourmelen M, Noguiez P et al. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab 1989;69:1291-1301
71. Hayashi S, Okimura Y, Yagi K, Uchiyama T, Takeshima Y, Shakatsui S. Intranasal administration of His-DTrp-Ala-Trp-D-Phe-Lys-NH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-1 in normal men. Endocrinol Jpn 1991; 38:15-21
72. Heuser IJE, Baronti F, Marin CA et al. Growth hormone secretion in Alzheimer's disease: 24-hour profile of basal levels and response to stimulation and suppression studies. Neurobiol Aging 1992;13:255-60
73. Hintz RL, Hoffmann AR, Butterfield G, Marcus R. The effects and side effects of growth hormone treatment in the adult. In: Laron Z, Butenandt O, eds. Growth Hormone Replacement Therapy in Adults Pros and Cons. London: Freund Publishing House, 1993;157-70
74. Ho KKY, Evans WS, Blizzard RM et al. Effects of sex and age on 24 hour profile of growth hormone secretion in men: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-8
75. Ho KKY, Hoffman DM. Aging and growth hormone. Horm Res 1993;40:80-6
76. Ho KKY, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue Metabolism. J Bone Miner Res 1992;7(7):821-7
77. Hochberg Z, Amit T, Zadick Z. Twenty four hour profile of plasma growth hormone-binding protein. J Clin Endocrinol Metab 1991;72:236-9
78. Hoffman D, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet 1994; 343:1064-8
79. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994;79:470-9
80. Holmes SJ, Economou G, Withehouse RW, Adams JE, Shalet sm. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78:669-74
81. Horber FF, Haymond MW. Human growth hormone prevents proteic catabolic side effects of prednisone in humans. J Clin Invest 1990;86:265-72
82. Hussain MA, Schmitz O, Mengel A et al. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation and enhances insulin sensitivity in humans. J Clin Invest 1993;92:2249-56
83. Iovino M, Monteleone P, Steardo L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH releasing hormone testing in normal aging. J Clin Endocrinol Metab 1989;69:910-3
84. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081-8
85. Isaksson OG, Jansson JO, Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science 1982;216: 1237-9
86. Jackson RA, Blix PM, Matthews JA, Hamling JB, Din BM, Brown DC. Influence of ageing on glucose homeostasis. J Clin Endocrinol Metab 1982;55:840-8
87. Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab 1993;77:1641-7
88. Jiang ZM, He GZ, Zhang SY et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989;210(4): 513-524
89. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995;44(9):1126-9
90. Johnson TR, Rudin SD, Blossey BK, Ilan J. Newly synthesized RNA: Simultaneous measurements in intact cells of transcription rates and RNA stability of insulin-like growth factor 1, actin and albumin in growth-hormone stimulated hepatocytes. Proc Natl Acad Sci USA 1991;88:5287-91
91. Jorgensen JOL, Moller N, Lauritzen T, Alberti KGMM, Oorskov H, Christiansen JS. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 1990;70:207
92. Jorgensen JOL, Pedersen SA, Thuessen L, Jorgensen J, Ingemann-Hansen T, Skakkebae K, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1:1221-5
93. Kaiser FH, Silver AJ, Morley JE. The effect of recombinant human growth hormone on malnourished older individuals. J Am Geriatr Soc 1991;39:235-40
94. Kalk WJ, Vinik AI, Pimstone BL, Jackson WP. Growth hormone responses to insulin hypoglycemia in the elderly. J Gerontol 1973;28:431-3
95. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY. Effects of different oral estrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 1993;39:561-7
96. Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH. Somatomedin-C, physical fitness and bone density. J Clin Endocrinol Metab 1990;70:718-23
97. Kuzuya H, Matsuura N, Sakamoto M, Makino H, Sakamoto H, Kadowaki T. Trial of insulin-like growth factor 1 therapy for patients with extreme insulin resistance syndromes. Diabetes 1993;42:696-705
98. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ M. Effects of sex and age on growth hormone response to growth hormone-releasing factor in healthy individuals. J Clin Endocrinol Metab 1987;65: 535-40
99. Laron Z, Klinger B, Erster B, Silbergeld A. Serum GH binding protein identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinol 1989;121:603-8
100. Le Roith D, Adamo M, Werner H, Roberts CT Jr. Insulin-like growth factors and their receptors as growth regulators in normal physiology and pathological states. Trends Endocrinol Metab 1991;2:134-9
101. Leung BW, Spencer SA, Cachianes G et al. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537
102. Link K, Blizzard R, Evans W, Kaiser D, Parker M, Rogol A. The effects of androgens on the pulsatile release and the 24 hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986;62:159-64
103. Liu L, Merriam GR, Sherins RJ. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987;64:651-6
104. Loche S, Cambiaso P, Carta D et al. The growth hormone releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children, and in hypopituitary subjects. J Clin Endocrinol Metab 1995a;80:674-8
105. Loche S, Cambiaso P, Merola B et al. The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J Clin Endocrinol Metab 1995b;80:2692-6
106. Marcus R, Butterfield G, Holloway L. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519-27
107. Marcus R, Holloway L, Butterfield G. Effects of growth hormone in older people. In: Bercu BB, Walker RF. eds. Growth Hormone II. Basic and Clinical Aspects. New York: Springer-Verlag, 1994;150-4
108. Markussi V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992;340:1188-92
109. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K. The effects of glucose on growth hormone (GH) releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 1985;60:523-6
110. Mc Gauley GA, Cuneo RC, Salomon F, Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 1990;33 Suppl 4:52-4
111. Merimee TJ, Pulkkinen A. Familial combined hyperlipoproteinemia: evidence for a role of growth hormone deficiency in effecting its manifestation. J Clin Invest 1980;65:829-35
112. Mjaaland M, Unneberg K, Hotvedt R, Revhaug A. Nitrogen retention caused by growth hormone in patients undergoing gastrointestinal surgery with epidural analgesia and parenteral nutrition. Eur J Surg 1991;157:21-7
113. Muggeo M, Feddele D, Tiengo A, Molinari M, Crepaldi G. Human growth hormone and cortisol responses to insulin stimulation in aging. J Gerontol 1975;30:546-51
114. Nass R, Huber RM, Klauss V, Muller OA, Schopohl, Strasburger CJ. Effects of grwth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 1995;80:552-75
115. Novack LP. Aging, total body potassium, fat-free mass and cell mass in males and females between ages 18 and 85 years. J Gerontol 1972;27:438-43
116. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993;76:1344-8
117. O'Keane V. GH-releasing neuropeptides. In: New perspectives in growth hormone therapy in adults. Second Cambridge Symposium at Queens College; 1993 Dec 12-14; Cambridge (UK), 1993;9-12
118. Pavlov EP, Harman SM, Merriam GR. Responses of growth hormone and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986; 62:595-600
119. Pietrowsky R, Meyrer R, Kern W, Born J, Fehm HL. Effects of diurnal sleep on secretion of cortisol, luteinizing hormone and growth hormone in man. J Clin Endocrinol Metab 1994;78:683-7
120. Poehlman ET, Copeland KC. Influence of physical activity on insulin-like growth factor 1 in healthy younger and older men. J Clin Endocrinol Metab 1990;71:1468:73
121. Pong SS, Chaung LYP, Dean DC, Nargund RP, Patchett AA, Smith RG. Identification of a new G-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10:57-61
122. Ponting GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988;27:438-40
123. Prinz P, Weitzman ED, Cunningham GR, Karacan I. Plasma growth hormone during sleep in young and aged men. J Gerontol 1983;38(5):519-24
124. Rivier J, Spiess J, Thorner M. Characterization of a growth hormone releasing factor from a human pancreatic islet tumor. Nature 1982;300:276-8
125. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-8
126. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 1993;38:63-71
127. Rosen T, Johannsson G, Johannsson JA, Bengtsson BA. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Norm Res 1995;43:93-9
128. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol 1994;40: 111-6
129. Ross RJM. Growth hormone replacement in adults: what dose? Clin Endocrinol 1993;39:401-2
130. Ross RJM, Miell JP, Freeman E et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor 1. Clin Endocrinol 1991;35:47-54
131. Rudman D, Feller AG, Nagraj HS et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6
132. RusselL-Jones DL, Weissberger AJ, Bowes SB et al. The effects of growth hormone on protein Metabolism in adult growth hormone deficient patients. Clin Endocrinol 1993;38:427-31
133. Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and Metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-803
134. Sassin JF, Parker DC, Mace JW, Gotlin RW, Johnson LC, Rossman LG. Human growth hormone release: relationship to slow wave sleep and sleep-waking cycles. Science, 1969;165:513-5
135. Shibasaki T, Shizume K, Nakahara M. Age-related changes in plasma growth hormone response to growth hormone releasing factor in man. J Clin Endocrinol Metab 1984; 58:212-4
136. Smith AT, Clemmons DR, Underwood LE, Ben-Ezra V, Mc Murray R. The effects of exercise on plasma insulin-like growth factor-1 concentrations. Metabolism 1987;36: 533-7
137. Smith IF, Latham MC, Azabuike JA, Butler WR, Phillips LS, Pond WG. Blood plasma levels of cortisol, insulin, growth hormone and somatomedin in children with marasmus, kwashiorkor and intermediate forms of protein-energy malnutrition. Proc Soc Exp Biol Med 1981;167:607-11
138. Snow KJ, Shaw MA, Winer LM, Baumann G. Diurnal pattern of plasma growth hormone-binding protein in man. J Clin Endocrinol Metab 1990;70:417-20
139. Snyder DK, Clemmons DR, Underwood LE. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects of anabolism, lipolysis and body composition. J Clin Endocrinol Metab 1988;67:54-61
140. Sonntag WE, Gough MA. Growth hormone releasing hormone induced release of growth hormone in aging male rats: Dependence on pharmacological manipulation and endogenous somatostatin release. NeuroEndocrinology 1988;47: 482-8
141. Svensen OL, Haarbo J, Heitmann BL, Gotfredsen A, Christiansen C. Measurement of body fat in elderly subjects by dual-energy X-ray absorptiometry, bioelectrical impedance and anthropometry. Am J Clin Nutr 1991;53:1117-23
142. Taaffe DR, Pruitt L, Reim J et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994;79:1361-6
143. Thoren M, Soop M, Degerblad M, Sääf M. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol 1993;128 (suppl 2):41-3
144. Treuth MS, Ryan AS, Pratley MA, Rubin JP, Miller JP, Nicklas BJ. Effects of strength training on total and regional body composition in older men. J Appl Physiol 1994; 77(2):614-20
145. Utiger RD. Extraction and radioimmunoassay of growth hormone in human serum. J Clin Endocrinol Metab 1964;24:60-7
146. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993;39:409-15
147. Vara-Thorbeck R, Guerrero JA, Rossel J, Ruiz-Requena E, Capitan JM. Exogenous growth hormone: effects on the calabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993;17: 530-8
148. Veldhuis JD, Iranmanesh A, Ho KY, Waters MJ, Johnson ML, Lizzaralde G. Dual defects in pulsatile growth hormone on body composition and Metabolism in adults with growth hormone deficiency. J Clin Endocrinol Metab 1991;72: 51-9
149. Voerman HJ, Strack van Schijndel RJM, Groeneveld ABJ et al. Nitrogen retention caused by growth hormone in patients undergoing gastrointestinal surgery with epidural analgesia and parenteral nutrition. Eur J Surg 1991;157:21-7
150. Ward HC, Halliday D, Sim AJW. Protein and energy Metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 1987;206(1):56-61
151. Weissberger AJ, Ho KY, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24 hour growth hormone (GH) secretion, insulin-like growth factor 1 and GH binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374-81
152. Weltman A, Weltman JY, Hartman ML et al. Relationship between age, percentage body fat, fitness and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 1994;78:543-8
153. Whitehead H, Boreham C, Mc Ilrath EM et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45-52
154. Yamashita S, Melmed S. Effects of insulin on rat anterior pituitary cells: inhibition of growth hormone secretion and mRNA levels. Diabetes 1986;35:440-47
155. Zenobi PD, Glatz Y, Keller A, Graf S, Jacggi-Groisman SE, Riesen WF. Beneficial metabolic effects of insulin-like growth factor-1 in patients with severe insulin resistant diabetes type A. Euro J Endocrinol 1994;1315(3):251-7
156. Zenobi PD, Holzmann P, Glatz Y, Riesen WE, Froesch ER: Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes by insulin-like growth factor-1. Diabetologica 1993;36:465-9
157. Zenobi PD, Jaeggi-Groisman SE, Riesen W, Roder M, Froesch ER. Insulin-like growth factor-I improves glucose and lipid Metabolism in type 2 diabetes mellitus. J Clin Invest. 1992;90:2234-41
158. Ziegler TR, Rombeau JL , Young LS et al. Recombinant human growth hormone enhances the metabolic efficiency of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992;74:865-73